Search research articles
Contact Us
Filters
Showing results (41-50 of 90) with videos related to
Page
of 9
Sort By:
Cancers
|
March 13, 2024
Dendritic Cells in Cancer Immunology and Immunotherapy
Laura Hato, Angel Vizcay, Iñaki Eguren, et al.
Journal of Hepatology
|
December 7, 2010
Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection
José-Ignacio Riezu-Boj, Esther Larrea, Rafael Aldabe, et al.
Oncotarget
|
October 27, 2017
Blockage of FOXP3 transcription factor dimerization and FOXP3/AML1 interaction inhibits T regulatory cell activity: sequence optimization of a peptide inhibitor
Teresa Lozano, Marta Gorraiz, Aritz Lasarte-Cía, et al.
Science Advances
|
July 10, 2024
Microproteins encoded by noncanonical ORFs are a major source of tumor-specific antigens in a liver cancer patient meta-cohort
Marta E Camarena, Patrick Theunissen, Marta Ruiz, et al.
Oncoimmunology
|
April 11, 2018
The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancer
Lorea Villanueva, Leyre Silva, Diana Llopiz, et al.
Journal of Hepatology
|
July 15, 2009
Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 protein
Cristina Mansilla, Marta Gorraiz, Marta Martinez, et al.
Cancer Letters
|
November 24, 2020
Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy
Diana Llopiz, Marta Ruiz, Leyre Silva, et al.
Biomed Research International
|
October 5, 2013
A fusion protein between streptavidin and the endogenous TLR4 ligand EDA targets biotinylated antigens to dendritic cells and induces T cell responses in vivo
Laura Arribillaga, Maika Durantez, Teresa Lozano, et al.
Cancer Immunology, Immunotherapy : CII
|
December 15, 2018
Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model
Diana Llopiz, Marta Ruiz, Lorea Villanueva, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
May 19, 2019
Therapeutic Effect of Irreversible Electroporation in Combination with Poly-ICLC Adjuvant in Preclinical Models of Hepatocellular Carcinoma
Isabel Vivas, Kristina Iribarren, Teresa Lozano, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 90) with videos related to
Sort By:
Page
of 9
Cancers
|
March 13, 2024
Dendritic Cells in Cancer Immunology and Immunotherapy
Laura Hato, Angel Vizcay, Iñaki Eguren, et al.
Journal of Hepatology
|
December 7, 2010
Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection
José-Ignacio Riezu-Boj, Esther Larrea, Rafael Aldabe, et al.
Oncotarget
|
October 27, 2017
Blockage of FOXP3 transcription factor dimerization and FOXP3/AML1 interaction inhibits T regulatory cell activity: sequence optimization of a peptide inhibitor
Teresa Lozano, Marta Gorraiz, Aritz Lasarte-Cía, et al.
Science Advances
|
July 10, 2024
Microproteins encoded by noncanonical ORFs are a major source of tumor-specific antigens in a liver cancer patient meta-cohort
Marta E Camarena, Patrick Theunissen, Marta Ruiz, et al.
Oncoimmunology
|
April 11, 2018
The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancer
Lorea Villanueva, Leyre Silva, Diana Llopiz, et al.
Journal of Hepatology
|
July 15, 2009
Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 protein
Cristina Mansilla, Marta Gorraiz, Marta Martinez, et al.
Cancer Letters
|
November 24, 2020
Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy
Diana Llopiz, Marta Ruiz, Leyre Silva, et al.
Biomed Research International
|
October 5, 2013
A fusion protein between streptavidin and the endogenous TLR4 ligand EDA targets biotinylated antigens to dendritic cells and induces T cell responses in vivo
Laura Arribillaga, Maika Durantez, Teresa Lozano, et al.
Cancer Immunology, Immunotherapy : CII
|
December 15, 2018
Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model
Diana Llopiz, Marta Ruiz, Lorea Villanueva, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
May 19, 2019
Therapeutic Effect of Irreversible Electroporation in Combination with Poly-ICLC Adjuvant in Preclinical Models of Hepatocellular Carcinoma
Isabel Vivas, Kristina Iribarren, Teresa Lozano, et al.
Page
of 9